
- Telehealth Visits
- Insurance plan information

Nancy Ann Oberheim Bush, MD, PhD
Neuro-Oncology- Telehealth Visits
- Insurance plan information
Neuro-Oncology Parnassus



Nancy Ann Oberheim Bush, MD, PhD
Neuro-OncologyNeuro-Oncology Parnassus
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Neuro-Oncology, University of CA at San Francisco - Urology GME
Degree
- MD, University of Rochester School of Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 82 reviews
Sort by
- March 16, 20265 out of 5 Stars
Nancy Ann is very kind and courteous.
- March 11, 20265 out of 5 Stars
Nice job team Bush !
- March 11, 20265 out of 5 Stars
Grateful to have doctors such as Dr. Bush. She's caring, addressing all my concerns in a clear and compassionate manner.
- March 4, 20265 out of 5 Stars
Dr. Oberheim Bush is a wonderful physician: intelligent, thoughtful, and personable. I feel lucky to have found her.
- February 4, 20265 out of 5 Stars
Nothing else to say, everything is just amazing!
- February 2, 20265 out of 5 Stars
Love seeing Dr. Bush during these video visits. Her Optimism is infectious!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.